Miguel Gancedo Rodrigo

Miguel Gancedo Rodrigo is a Research Investigator specializing in In Vitro Pharmacology at Isomorphic Labs since October 2023. Previously, Miguel served as a Principal Scientist and Biology Project Leader at BenevolentAI, overseeing small molecule drug discovery projects from hit identification to preclinical development. Miguel's experience includes a role as a Senior Research Scientist at AstraZeneca, where Miguel contributed to Oncology and Neuroscience projects, and as a Laboratory Research Officer at The Francis Crick Institute, focusing on the kinetics of E. coli RecA recombinase. Miguel's education includes a Master's degree in Cancer Pharmacology from London Metropolitan University and a Master's in Pharmacy from Universidad de Murcia.